Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ
8.61
+0.17 (+2.01%)
Closed
Sep 18, 2026
Day's Range
8.408.75
52 wk Range
2.2914.53
Financial Statements - ARTV - Artiva Biotherapeutics, Inc.
Revenue
0▼ 100.0%
Net Income
-83.86M▼ 21.2%
EBITDA
-87.21M▼ 34.5%
Free Cash Flow
-79.33M▼ 42.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 251K | 33.49M | 4.93M | 2M | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -89.81M | -67.28M | -30.67M | -59.82M | -53.27M | -18.27M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -14K | 3.44M | 512K | 200K | -18.55M | 477K |
| Pre Tax Income | -83.86M | -69.19M | -27.62M | -58.33M | -71.82M | -17.99M |
| Income Tax | - | 0 | 72K | 53K | - | - |
| Net Income | -83.86M | -69.19M | -27.69M | -58.38M | -71.82M | -17.99M |
| EPS Basic | -3.43 | -5.81 | -3.07 | -6.236994 | -7.672332 | -1.921795 |
| EPS Diluted | -3.43 | -5.81 | -3.07 | -6.236994 | -7.672332 | -1.921795 |
| Basic Shares Outstanding | 24.44M | 11.25M | 9.35M | 9.36M | 9.36M | 9.36M |
| Diluted Shares Outstanding | 24.44M | 11.25M | 9.35M | 9.36M | 9.36M | 9.36M |
| Ebit | -89.81M | -67.28M | -30.67M | -59.82M | -71.82M | -17.79M |
| Ebitda | -87.21M | -64.85M | -29.11M | -58.67M | -71.57M | -17.71M |
| Net Income Continuous Operations | -83.86M | -65.37M | -28.72M | -58.78M | -71.82M | -17.99M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
